Guggenheim Capital LLC Turning Point Therapeutics, Inc. Transaction History

Guggenheim Capital LLC

  • $14 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$24.32 - $75.3 $237,728 - $736,057
9,775 Added 79.43%
22,082 $1.66 Million
Q1 2022

May 16, 2022
BUY
$24.73 - $51.25 $12,463 - $25,830
504 Added 4.27%
12,307 $330,000
Q4 2021

Feb 14, 2022
BUY
$35.48 - $67.33 $36,012 - $68,339
1,015 Added 9.41%
11,803 $563,000
Q3 2021

Nov 15, 2021
BUY
$61.0 - $81.99 $91,805 - $123,394
1,505 Added 16.21%
10,788 $717,000
Q2 2021

Aug 13, 2021
BUY
$62.93 - $90.59 $76,585 - $110,248
1,217 Added 15.09%
9,283 $724,000
Q1 2021

May 13, 2021
BUY
$88.19 - $140.01 $339,178 - $538,478
3,846 Added 91.14%
8,066 $763,000
Q4 2020

Feb 16, 2021
BUY
$87.69 - $130.94 $370,051 - $552,566
4,220 New
4,220 $514,000

About Turning Point Therapeutics, Inc.

TPTX Quotes by TradingView
  • Ticker TPTX
  • Exchange NASDAQ
  • Shares Outstandng 50,074,300
More about TPTX
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email